188体育

We are committed to delivering a step-change in the way we engage with patients and the public, putting their views and interests at the heart of our decision-making and culture.

We are taking steps to adopt a more transparent, responsive and systematic approach to listening to and involving patients and the public.

Our approach to patient and public involvement

Our first聽Patient Involvement Strategy published in October 2021 set out how we will engage and involve the public and patients at every step of the regulatory journey. Our approach was informed at the very outset through consultation with patients on what was important to them.聽The Independent Medicines and Medical Devices Safety Review聽also provided us with clear direction on where we could improve our engagement with patients, and the resulting strategy was then approved by our Patient Safety and Engagement Committee and Agency Board.

If you would like to read about some of our activities within the first year of the strategy, please see our聽One Year On report聽for more information.

Patient and Public Community

The Patient and Public Community (previously known as the Patient Group Consultative Forum) was established in October 2024 following the review of our strategy and how we could improve involvement of our Patient and Public community.

It is open to people with an interest in medicines and medical devices, and to patient groups who can represent the views of their members and feed these into discussions. It acts as a means of bringing the 鈥榩atient/public voice鈥� into the agency, to assist in our development of policy or our approach to a specific regulatory or scientific research areas.

We expect participants in the Community to be able to meet the following criteria:

• a demonstrable interest in medicines and medical devices and the role they play in improving health and increasing quality of life
• an interest in the regulation of medicines and medical devices
• an interest in science and research
• a commitment to the principles of patient and public engagement and involvement
• an ability to draw on their experiences as a patient and as a consumer of medicines and medical devices and translate this into a population level perspective
• an interest in championing patient safety
• the commitment to participate in the work of the agency by attending the Patient and Public Community meetings and participating in electronic methods of engagement
• an ability to respect boundaries and confidentiality
• an ability to contribute constructively to discussions
• an ability to communicate effectively
• a commitment to the agency values:
  • innovative
  • proactive
  • impartial
  • evidence-based
  • open
  • trustworthy

The Community is managed by our Patient, Public and Stakeholder Engagement team and comprises of representation from patient groups/networks and charities/research charities or individual patients or carers.

What community members will do

As a member of the community, you can:

• Influence and inform our work by sharing your insights and perspectives
• Help us to improve how we involve patients, carers and the public in our work
• Stay informed of our key developments
• Use your lived experience, or that of the community you represent, to help others to be engaged with our work

We will host events focused on a specific area of the agency鈥檚 work. This will provide community members to learn more about our activities and meet agency staff. Community members will also have opportunity to provide comments (from the patient/carer perspective) on draft materials and participate in surveys that inform the development of our work.

Get involved

We continue to grow and evolve and are keen to gain a wide and diverse range of patients and conditions for the Patient and Public Community. There are two types of membership 鈥� individual or voluntary and community sector. If you or your organisation would like to get involved, either as a representative of a patient group, or charity/research charity, or as a patient or a carer, sign up using the relevant 鈥楨xpression of interest鈥� form. Before you sign up, please ensure that you have read and understood our .

Public sessions of the Board

Each year we aim to hold six sessions of the Agency Board meetings in public.

厂别别听further details of these public sessions, including how to register to attend. You can if you would like to be kept updated about Agency Board meetings in public and 聽also find out about what is going on in the MHRA that might be of interest to you, plus news about involvement activities聽 that are happening outside the MHRA but are linked to our work.

Details about the agency鈥檚 governance can be found on the relevant pages for 鈥極ur governance鈥� and聽鈥橝dvisory bodies鈥櫬� including their respective responsibilities and members.

Agency鈥檚 commitment to patient engagement and involvement

Our commitment to patient and public engagement is included in the agency鈥檚聽Corporate Plan 2023-26.

We are a signatory of the聽shared commitment to public involvement in research. Read more in our blog聽.